Characterisation of the biological activity of xenin-25 degradation fragment peptides

CA Martin; V Parthsarathy; V Pathak; Victor Gault; Peter Flatt; Nigel Irwin

doi:10.1530/JOE-13-0617.R1

Characterisation of the biological activity of xenin-25 degradation fragment peptides

CA Martin
, V Parthsarathy
, V Pathak
, Victor Gault
, Peter Flatt
, Nigel Irwin

Research output: Contribution to journal › Article › peer-review

32 Citations (Scopus)

Abstract

Xenin-25, a peptide co-secreted with the incretin hormone glucose-dependent insulinotropic polypeptide (GIP), possesses promising therapeutic actions for obesity-diabetes. However, native xenin-25 is rapidly degraded by serum enzymes to yield the truncated metabolites xenin 9-25, xenin 11-25, xenin 14-25 and xenin 18-25. The present study has examined the biological activities of these fragment peptides. In vitro studies using BRIN BD11 cells demonstrated that native xenin-25 and xenin 18-25 possessed significant (P

Original language	English
Pages (from-to)	193-200
Journal	Journal of Endrocrinology
Volume	221
Issue number	2
DOIs	https://doi.org/10.1530/JOE-13-0617.R1
Publication status	Published (in print/issue) - 22 Apr 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1530/JOE-13-0617.R1

Cite this

@article{6ccc8a9046434307aa1d0152d3da77d3,

title = "Characterisation of the biological activity of xenin-25 degradation fragment peptides",

abstract = "Xenin-25, a peptide co-secreted with the incretin hormone glucose-dependent insulinotropic polypeptide (GIP), possesses promising therapeutic actions for obesity-diabetes. However, native xenin-25 is rapidly degraded by serum enzymes to yield the truncated metabolites xenin 9-25, xenin 11-25, xenin 14-25 and xenin 18-25. The present study has examined the biological activities of these fragment peptides. In vitro studies using BRIN BD11 cells demonstrated that native xenin-25 and xenin 18-25 possessed significant (P",

author = "CA Martin and V Parthsarathy and V Pathak and Victor Gault and Peter Flatt and Nigel Irwin",

year = "2014",

month = apr,

day = "22",

doi = "10.1530/JOE-13-0617.R1",

language = "English",

volume = "221",

pages = "193--200",

journal = "Journal of Endrocrinology",

issn = "1479-6805",

publisher = "BioScientifica Ltd.",

number = "2",

}

TY - JOUR

T1 - Characterisation of the biological activity of xenin-25 degradation fragment peptides

AU - Martin, CA

AU - Parthsarathy, V

AU - Pathak, V

AU - Gault, Victor

AU - Flatt, Peter

AU - Irwin, Nigel

PY - 2014/4/22

Y1 - 2014/4/22

N2 - Xenin-25, a peptide co-secreted with the incretin hormone glucose-dependent insulinotropic polypeptide (GIP), possesses promising therapeutic actions for obesity-diabetes. However, native xenin-25 is rapidly degraded by serum enzymes to yield the truncated metabolites xenin 9-25, xenin 11-25, xenin 14-25 and xenin 18-25. The present study has examined the biological activities of these fragment peptides. In vitro studies using BRIN BD11 cells demonstrated that native xenin-25 and xenin 18-25 possessed significant (P

AB - Xenin-25, a peptide co-secreted with the incretin hormone glucose-dependent insulinotropic polypeptide (GIP), possesses promising therapeutic actions for obesity-diabetes. However, native xenin-25 is rapidly degraded by serum enzymes to yield the truncated metabolites xenin 9-25, xenin 11-25, xenin 14-25 and xenin 18-25. The present study has examined the biological activities of these fragment peptides. In vitro studies using BRIN BD11 cells demonstrated that native xenin-25 and xenin 18-25 possessed significant (P

U2 - 10.1530/JOE-13-0617.R1

DO - 10.1530/JOE-13-0617.R1

M3 - Article

SN - 1479-6805

VL - 221

SP - 193

EP - 200

JO - Journal of Endrocrinology

JF - Journal of Endrocrinology

IS - 2

ER -

Characterisation of the biological activity of xenin-25 degradation fragment peptides

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this